Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk.
McCoy RG, Herrin J, Swarna KS, Deng Y, Kent DM, Ross JS, Umpierrez GE, Galindo RJ, Crown WH, Borah BJ, Montori VM, Brito JP, Neumiller JJ, Mickelson MM, Polley EC.
McCoy RG, et al. Among authors: deng y.
Nat Cardiovasc Res. 2024 Apr;3(4):431-440. doi: 10.1038/s44161-024-00453-9. Epub 2024 Apr 3.
Nat Cardiovasc Res. 2024.
PMID: 38846711
Free PMC article.